Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

China flag China · Delayed Price · Currency is CNY
16.33
-0.23 (-1.39%)
May 21, 2026, 3:04 PM CST
Market Cap3.58B -6.1%
Revenue (ttm)265.79M -26.0%
Net Income-13.18M
EPSn/a
Shares Out219.49M
PE Ration/a
Forward PEn/a
Dividend1.20 (7.31%)
Ex-Dividend DateJun 12, 2025
Volume2,607,481
Average Volume4,514,432
Open16.58
Previous Close16.56
Day's Range16.28 - 16.69
52-Week Range15.28 - 23.28
Beta0.41
RSI45.29
Earnings DateSep 1, 2026

About SHE:002932

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally. Its products portfolio includes molecular diagnostic products, such as drug metabolism genetic testing and pathogen nucleic acid detection kits; and immunodiagnostic and blood gas diagnosis products. The company also provides emergency and critical illness information solutions, including information software products, supporting hardware, and certification... [Read more]

Sector Healthcare
Founded 2008
Employees 812
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002932
Full Company Profile

Financial Performance

Financial Statements